Drug Description in Trials / DrugBank / KEGG DRUG /

Search results

No.	薬物名（臨床試験情報から抽出）	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY	指定難病告示番号
1	C03XA01	-	-	-	-	2件: 67, 72
2	Desmopressin	1件: Desmopressin	2件: D00291 , D02235	2件: AVPR2, F8 💬	4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬	5件: 6, 64, 72, 225, 288
3	Desmopressin intranasal	1件: Desmopressin	2件: D00291 , D02235	2件: AVPR2, F8 💬	4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬	1件: 72
4	Desmopressin Oral Melt	1件: Desmopressin	2件: D00291 , D02235	2件: AVPR2, F8 💬	4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬	1件: 72
5	Empagliflozin	1件: Empagliflozin	1件: D10459	1件: SLC5A2 💬	-	5件: 65, 72, 96, 97, 257
6	Empagliflozin 25 MG	1件: Empagliflozin	1件: D10459	1件: SLC5A2 💬	-	1件: 72
7	Empagliflozin 25mg	1件: Empagliflozin	1件: D10459	1件: SLC5A2 💬	-	1件: 72
8	Empagliflozin 25mg Tbl	1件: Empagliflozin	1件: D10459	1件: SLC5A2 💬	-	1件: 72
9	EXENATIDE	1件: Exenatide	1件: D04121	1件: GLP1R 💬	3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬	6件: 6, 17, 72, 78, 193, 233
10	Experimental: CRH administration	-	-	-	-	2件: 72, 78
11	Experimental: GLP1-RA (exenatide) administration	1件: Exenatide	1件: D04121	1件: GLP1R 💬	3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬	2件: 72, 78
12	IUPAC	-	-	-	-	1件: 72
13	Other: Fluid Restriction	-	-	-	-	1件: 72
14	Other: Induced hypotonic hyponatremia - SIAD model	-	-	-	-	1件: 72
15	Oxytocin	1件: Oxytocin	1件: D00089	1件: OXTR 💬	4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬	6件: 6, 72, 127, 193, 206, 226
16	Oxytocin nasal spray	1件: Oxytocin	1件: D00089	1件: OXTR 💬	4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬	1件: 72
17	Samsca	1件: Tolvaptan	1件: D01213	1件: AVPR2 💬	3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬	2件: 67, 72
18	SAMSCA*10CPR 15MG	1件: Tolvaptan	1件: D01213	1件: AVPR2 💬	3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬	1件: 72
19	Satavaptan	1件: Satavaptan	-	-	-	1件: 72
20	Satavaptan (SR121463)	1件: Satavaptan	-	-	-	1件: 72
21	Satavaptan (SR121463B)	1件: Satavaptan	-	-	-	1件: 72
22	SR121463B	-	-	-	-	1件: 72
23	TOLVAPTAN	1件: Tolvaptan	1件: D01213	1件: AVPR2 💬	3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬	3件: 67, 72, 225
24	Tolvaptan (SAMSCA)	1件: Tolvaptan	1件: D01213	1件: AVPR2 💬	3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬	1件: 72
25	Tolvaptan in euvolemic hyponatremia	1件: Tolvaptan	1件: D01213	1件: AVPR2 💬	3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬	1件: 72
26	Tolvaptan Oral Tablet	1件: Tolvaptan	1件: D01213	1件: AVPR2 💬	3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬	1件: 72
27	Urea	1件: Urea	2件: D00023 , D01749	-	-	2件: 72, 251